Routine use of haloperidol or second-generation antipsychotics to treat delirium in hospitalized adults does not lead to improved patient outcomes, with little evidence of neurologic harms but a tendency for more frequent potentially harmful cardiac effects, a study has shown.
Continuous primary care follow-up during the transition from adolescence to young adulthood could reduce the risk of mental illness-related hospitalizations post-transition in individuals with severe mental illness, according to a Canadian study.
Seven healthcare organizations will collaborate with a pharmaceutical company on building an integrated care ecosystem among private healthcare professionals (HCPs) to manage noncommunicable diseases (NCDs).
Incorporating yoga as a complementary therapy to standard pharmacological treatment of migraine helps reduce the frequency and intensity of migraine and its impact on the lives of people with such condition, according to the CONTAIN* study presented at the 2019 AHS Meeting.
A recent analysis of 1,289 individuals across normal, overweight and obese Body Mass Index (BMI) ranges demonstrated that higher BMI and waist circumference values were significantly associated with thinner brain cortices.
A recently published prospective cohort study involving 2,000 individuals ≥70 years of age demonstrated that engaging in mentally stimulating activities, such as computer use, social and craft activities and playing games, was associated with a decreased risk of mild cognitive impairment (MCI).
New drug applications approved by US FDA as of 16 - 31 July 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
In this issue of MIMS PsychiatrySupplement, we bring you clinical updates related to managing depression and optimizing functional recovery in patients with depression, as well as a symposium highlight of the Lundbeck Malaysia Neuroscience Symposium.